Johnson M A, Yamamoto T, Klinger H. "Method for the Synthesis of (5-Methyl-1,2,4-oxadiazol-3-yl)methanamine;hydrochloride" [P]. US Patent, US 10817207 B2, 2024-09-12.
Chen K W, O'Brien P Q, Kumar R. "A Process for Preparing High-Purity (5-Methyl-1,2,4-oxadiazol-3-yl)methanamine;hydrochloride" [P]. US Patent, US 11909035 B2, 2021-08-18.
参考文献 Literature
Martinez C, Lopez D R. "Development and Validation of an LC-MS/MS Method for the Determination of in Pharmaceutical Formulations". Food Chem., 2012, 2225, (4), 839-865.
Smith J A, Johnson M B. "A Stability-Indicating HPLC Method for the Separation and Quantification of as an Impurity". Anal. Methods, 2018, 2340, (9), 7326-7332.
Kumar A, Sharma P, Patel R S. "Identification and Structural Characterization of a Novel Degradation Product of (5-Methyl-1,2,4-oxadiazol-3-yl)methanamine;hydrochloride Using HRMS and NMR". J. Pharm. Biomed. Anal., 2019, 1208, 6364-6392.
Zhang Y, Li Q, Chen T. "Forced Degradation Studies to Evaluate Profile in Drug Substances According to ICH Guidelines". Sci. Total Environ., 2015, 83, (3), 8476-8486.